Return to Faculty List

Faculty

Douglas L. Jennings

Professor, Pharmacy PracticeDirector of Assessment and AccreditationDirector, Advanced Heart Failure/Transplant Pharmacy Fellowship

Pharm.D., Wayne State University, Detroit, MI

Description

Dr. Jennings is an Associate Professor of Pharmacy at Long Island University, and he currently practices as the Clinical Pharmacist in Heart Transplant and Mechanical Circulatory Support at NewYork Presbyterian Columbia University Medical Center. He is an active researcher in his field, and he has published over 120 peer-reviewed abstracts and manuscripts, primarily focusing on the pharmacotherapy of patients under mechanical circulatory support. As a recognized expert in this area, he has been invited to speak at numerous national and international venues, including meetings in France, Saudia Arabia, India. Also, he was recently invited to co-author the 2020 update to the International Society of Heart and Lung Transplantion Guidelines for the Care of Heart Transplant Recipients. Finally, Dr. Jennings has been active in professional organizations throughout his career. He currently sits on Advanced Heart Failure and Transplant Leadership Council for the American College of Cardiology and the Programming Committee for the 2019 Annual Meeting for the Heart Failure Society of America. He is a fellow of the American College of Clinical Pharmacy, the American College of Cardiology, the American Heart Association, and the Heart Failure Society of America.

Specialties

Cardiology, heart transplant, mechanical circulatory support

Publications

Medical Writing & Editorial

  • Annenberg Center for Health Sciences, Medical Writer
  • "Talking Therapeutics" Pharmacy Learning Network, Weekly Columnist
  • Journal of Cardiac Failure, Editorial Board Member

Original Clinical Science

h-index = 23, i10 index = 46, *=Corresponding Author

  • Pinsino A, Carey MR, Syed H, Mohan S, Radhakrishnan J, Jennings DL, Nguonly AS, Ladanyi A, Braghieri L, Takeda K, Faillace RT, Sayer GT, Uriel N, Colombo PC, Yuzefpolskaya M. The Difference Between Cystatin C- and Creatinine-Based eGFR in Heart Failure With Reduced Ejection Fraction: Insights From PARADIGM-HF. Am J Kidney Dis 2023 Apr 20;S0272- 6386(23)00609-1. doi: 10.1053/j.ajkd.2023.03.005.
  • Jennings DL, Baker WL. Impact of the United Network for Organ Sharing Policy Change on Induction Immunosuppression Practice Patterns and Outcomes in Adult Heart Transplant Recipients. Pharmacotherapy 2023;43:115-121.
  • Baker WL, Moore TE, Baron E, Jennings DL, Jaiswal A. Development and Validation of a Model to Predict Malignancy Within the First Year After Adult Heart Transplantation. Prog Transplant 2023;33:69-77.
  • Golob S, Batra J, DeFilippis EM, Uriel M, Carey M, Gaine M, Mabasa A, Fried J, Raikelkar J, Restaino S, Hi Lee S, Latif F, Yuzefpolskaya M, Colombo PC, Choe J, Majure D, Jennings DL, Pereira MR, Clerkin K, Sayer G, Uriel N. Letermovir for Cytomegalovirus Prophylaxis in High Risk Heart Transplant Recipients. Clin Transplant 2022;36(12):e14808.
  • Braghieri L, Jennings DL, Bohn B, Habal M, Pinsino A, Mondellini GM, Ladanyi A, Latif F, Clerkin K, Restaino S, Kurlansky P, Takeda K, Naka Y, Demmer RT, Sayer GT, Uriel N, Colombo PC, Yuzefpolskaya M. Temporal shifts in safety and efficacy profile of mycophenolate mofetil 2 g versus 3 g daily early after heart transplantation. Pharmacotherapy2022;42(9):697-706.
  • Shertel T, Lange NW, Salerno DM, Hedvat J, Jennings DL, Choe JY, Brown RS Jr, Pereira MR. Bebtelovimab for Treatment of COVID-19 in Ambulatory Solid Organ Transplant Recipients. Transplantation 2022;106(10):e463-e464.
  • Hedvat J, Lange NW, Salerno DM, DeFilippis EM, Kovac D, Corbo H, Chen JK, Choe JY, Lee JH, Anamisis A, Jennings DL, Codispodo G, Shertel T, Brown RS Jr, Pereira MR. COVID-19 therapeutics and outcomes among solid organ transplant recipients during the Omicron BA.1 era. Am J Transplant 2022 Jul 8. doi: 10.1111/ajt.17140.
  • Jennings DL*, Sultan L, Mingov J, Choe J, Latif F, Restaino S, Clerkin K, Habal MV, Colombo PC, Yuzefpulskaya M, Sayer G, Uriel N, Baker WL. PCSK9 inhibitors safely and effectively lower LDL after heart transplantation: a systematic review and meta-analysis. Heart Fail Rev 2022 Jun 10th doi: 10.1007/s10741-022-10255-
  • Salerno DM, Jennings DL, Lange NW, Bley Kovac D, Shertel T, Chen JK, Hedvat J, Scheffert J, Brown RS Jr, Pereira MR. Early clinical experience with nirmatrelvir/ritonavir for treatment of COVID-19 in solid organ transplant recipients. Am J Transplant 2022;22(8):2083-2088.
  • Lumish HS, Cagliostro B, Braghieri L, Bohn B, Mondellini GM, Antler K, Feldman V, Kleet A, Murphy J, Tiburcio M, Fidlow K, Jennings DL, Sayer GT, Takeda K, Naka Y, Demmer RT, Aaron JG, Uriel N, Colombo PC, Yuzefpolskaya M. Driveline Infection in Left Ventricular Assist Device Patients: Effect of Standardized Protocols, Pathogen Type, and Treatment Strategy ASAIO J. 2022 Mar 1. doi: 10.1097/MAT.0000000000001690.
  • Hedvat J, Salerno DM, Kovac D, Scheffert JL, Corbo H, Chen JK, Choe JY, Jennings DL, Anamisis A, Liu EC, Lee JH, Shertel T, Lange NW. Nitazoxanide treatment for norovirus infection in solid organ transplant recipients. Clin Transplant 2022;36(3):e14594.
  • Yopes M, Fanek T, Fuselier B, Gaine M, Jackson R, Mabasa A, Kim A, Jennings DL, Clerkin K, Yuzefpolskaya M, Habal M, Latif F, Restaino S, Lee SH, Farr M, Colombo P, Sayer G, Uriel N. Chronic intermittent intravenous immunoglobulin in heart transplant recipients with elevated donor-specific antibody levels. Clin Transplant 2022; 36(2):e14524.
  • Jaiswal A, Gadela NV, Baran DA, Dasgupta O, Gluck J, Radojevic J, Arora S, Scatola A, Ali A, Hammond J, Jennings DL, Baker WL. Post Heart Transplantation Outcomes of Patients Supported on Biventricular Mechanical Support. ASAIO J 2021;68(7):914-919.
  • Salerno DM, Thornberg ME, Lange NW, Hedvat J, Robbins H, Brown RS, Jennings DL,* Scheffert J. Less bleeding associated with apixaban versus other direct acting oral anticoagulation in solid organ transplant recipients. Clin Transplant 2021;35(12):e14396.
  • Jaiswal A, Gadela NV, Baran D, Balakumaran K, Scatola A, Radojevic J, Gluck J, Arora S, Hammond J, Ali A, Jennings DL, Baker WL. Clinical outcomes of older adults listed for heart transplantation in the United States. J Am Geriatr Soc 2021;69:2507-2517.
  • Jennings DL,* Truby LK, Littlefield AJ, Ciolek AM, Marshall D, Jain R, Topkara VK. Impact of heart failure drug therapy on rates of gastrointestinal bleeding in LVAD recipients: An INTERMACS analysis. Int J Artif Organs 2021;44:965–971.
  • Jennings DL, Gadela NV, Jaiswal A, Touch A, Baker WL. Pre-transplant amiodarone use does not affect long-term heart transplant survival. Pharmacotherapy 2021;41:1024-1032.
  • Alishetti S, Braghieri L, Jennings DL, Uriel N, Colombo PC, Yuzefpolskaya M. Angiotensin receptor neprilysin inhibitor use in patients with left ventricular assist devices: A single- center experience. Int J Artif Organs 2022;45:118-120.
  • Salerno DM, Bley D, Corbo H, Jennings DL, Lee J, Choe J, Scheffert J, Hedvat J, Chen J, Tsapepas D, Rosenblatt R, Samstein B, Halazun K, Verna E, Pereira M, Brennan C, Husain SA, Mohan S, Brown RS Jr. SARS-CoV-2 infection increases tacrolimus concentrations in solid- organ transplant recipients. Clin Transplant 2021;35:e14193.
  • Jiang C, Stuart M, Makowski C, Jennings DL, To L. Safety and Efficacy of a Percutaneously Inserted Ventricular Support Device Purge Solution Heparin 25 U/mL. Ann Pharmacother. 2021;55:174-180.
  • Saha A, Jennings DL, Ning Y, Kurlansky P, Miltiades AN, Spellman JL, Sanchez J, Yuzefpolskaya M, Colombo PC, Takayama H, Naka Y, Takeda K. Methylene blue does not improve vasoplegia following left ventricular assist device implantation. Ann Thorac Surg 2021;111:800-808.
  • Alishetti S, Farr M, Jennings DL, Serban G, Uriel N, Sayer G, Vasilescu R, Restaino S, Chong AS, Habal MV. Desensitizing Highly Sensitized Heart Transplant Candidates With the Combination of Belatacept and Proteasome Inhibition. Am J Transplant 2020:20:3620-3630.
  • Jennings DL,* Bohn B, Zuver A, Onat D, Gaine M, Royzman E, et al. Gut microbial diversity, inflammation, and oxidative stress are associated with tacrolimus dosing requirements early after heart transplantation. PLoS ONE 2020;15(5):e0233646.
  • Truby LK, Batra J, Jennings DL, Takeda K, DeFilippis EM, Takayama H, Naka Y, Farr MA, Topkara VK. Impact of Induction Immunosuppression on Post-Transplant Outcomes of Patients Bridged with Contemporary Left Ventricular Assist Devices. ASAIO J 2020;66:261- 267.
  • Hoemann B, Takayama H, Jennings DL, Han J, Ando M, Restaino S, Colombo P, Farr M, Naka Y, Takeda K. Discontinuing Amiodarone Treatment Prior to Heart Transplantation Lowers Incidence of Severe Primary Graft Dysfunction. Clin Transplant 2020;34:e13779.43.
  • Ciolek AM, Ma K, Garan AR, Eisenberger AB, Jennings DL.* Use of cangrelor during venoarterial extracorporeal membrane oxygenation following percutaneous coronary intervention. Artificial Organs 2020;44:339-340.
  • Beavers CJ, Jennings DL. Use of glycoprotein IIb/IIIa inhibitors in the modern era of acute coronary syndrome management: A survey of cardiovascular clinical pharmacists. J Pharm Pract 2020;32:77-92.
  • Jennings DL,* Jackson R, Farr MJ. PCSK9 inhibitor use in heart transplant recipients: A Case Series and Review of the Literature. Transplantation 2020;104:e38-e39.
  • Reed BN, Didomenico RJ, Allender JE, Coons JC, Cox JF, Oliphant CS, Jennings DL. Survey of anticoagulation practices with the Impella percutaneous ventricular assist device at high- volume centers. J Interv Cardiol 2019;3791307.
  • Breslin NT, Salerno DM, Topkara VK, Latif F, Restaino S, Takeda K, Takayama H, Farr M, Colombo PC, Jennings DL.* Prior Amiodarone Exposure Reduces Tacrolimus Dosing Requirements in Heart Transplant Recipients. Prog Transplant 2019;29;129-134.
  • Truby LK, Sridharan L, Flores RJ, Garan AR, Jennings D, Yuzefpolskaya, M, Takeda K, Takayama H, Naka Y, Colombo PC, Topkara VK. Red Cell Distribution Width Predicts 90 Day Mortality in Continuous-Flow Left Ventricular Assist Device Patients. ASAIO J 2019;65:233-40.
  • Jennings DL,* Lange N, Shullo M, Latif F, Restaino S, Topkara VK, Takeda K, Takayama H, Naka Y, Farr M, Colombo P, Baker WL. Outcomes associated with mammalian target of rapamycin (mTOR) inhibitors in heart transplant recipients: A meta-analysis. Int J Cardiol 2018;265:71-76.
  • Martinez BK, Yik B, Tran R, Ilham S, Coleman CI, Jennings DL, Baker WL. Meta-Analysis of Time in Therapeutic Range in Continuous-Flow Left Ventricular Assist Device Patients Receiving Warfarin. Artif Organs 2018;42:700–704.
  • Lee CL, Colombo PC, Eisenberger A, Diuguid D, Jennings DL, Han J, Salna MP, Takeda K, Kurlansky PA, Yuzefpolskaya M, Garan AR, Naka Y, Takayama H. Abciximab/Heparin Therapy for Left Ventricular Assist Device Implantation in Patients With Heparin-Induced Thrombocytopenia. Ann Thorac Surg 2018;105:122-128.
  • Wright M, Takeda K, Mauro C, Jennings D, Kurlansky P, Han J, Truby L, Stein S, Topkara V, Garan AR, Yuzefpolskaya M, Colombo P, Naka Y, Farr M, Takayama H. Dose-dependent association between amiodarone and severe primary graft dysfunction in orthotopic heart transplantation. J Heart Lung Transplant 2017;36:1226-1233.
  • Jennings DL,* Baker WL. Pre-cardiac transplant amiodarone use is not associated with postoperative mortality: An updated meta-analysis. Int J Cardiol 2017; 236:345-347.
  • Topkara VK, Coromilas EJ, Garan AR, Li RC, Castagna F, Jennings DL, Yuzefpolskaya M, Takeda K, Takayama H, Sladen RN, Mancini DM, Naka Y, Radhakrishnan J, Colombo PC. Preoperative Proteinuria and Reduced Glomerular Filtration Rate Predicts Renal Replacement Therapy in Patients Supported With Continuous-Flow Left Ventricular Assist Devices. Circ Heart Fail 2016 Dec;9(12). pii: e002897.
  • Ton KV, Eisenberger A, Jennings DL, Colombo PC, Topkara VK. Relationship of hemolysis with discordance in paired activated partial thromboplastin time and anti-factor Xa measurements in continuous-flow left ventricular assist device patients. J Heart Lung Transplant 2016;35:1365-67.
  • Topkara VK, Knotts RJ, Jennings DL, Garan AR, Levin AP, Breskin A, Castagna F, Cagliostro B, Yuzefpolskaya M, Takeda K, Takayama H, Uriel N, Mancini DM, Eisenberger A, Naka Y, Colombo PC, Jorde UP. Effect of CYP2C9 and VKORC1 Gene Variants on Warfarin Response in Patients with Continuous-Flow Left Ventricular Assist Devices (CF-LVADs). ASAIO J 2016;62:558-64.
  • Kuyumjian YM, Leverock J, Miyares MA, Bednar B, Chaparro S, Panos A, Baker WL, Jennings DL.* A multidisciplinary team-based process improves anticoagulation quality in patients with continuous-flow left-ventricular assist devices. Int J Cardiol 2016;218:118- 119.
  • Baker WL, Jennings DL. Pre-cardiac Transplant Amiodarone Use Increases Postoperative Mortality: A Meta-analysis. Ann Pharmacother 2016; 50:514–515.
  • Jennings DL,* Horn ET, Lyster H, Panos AL, Teuteberg JJ, Lehmkuhl HB, Perez A, Shullo MA. Assessing anticoagulation practice patterns in patients on durable mechanical circulatory support devices: An international survey. ASAIO J 2016;62:28-32.
  • Jennings DL,* Wagner JL, Nemerovski CW, Kalus JS, Morgan JA, Lanfear DE. Epidemiology and Outcomes Associated With Anemia During Long-Term Continuous-Flow Left Ventricular Assist Device Support. J Card Fail 2014;20:387-391.
  • Jennings DL,* Jacob M, Chopra A, Nemerovski C, Morgan JA, Lanfear DE. Safety of anticoagulation reversal in patients supported with continuous-flow left-ventricular assist devices. ASAIO J 2014;60:381-384.
  • Sadik SG, Jennings DL, Nemerovski CW, Kuriakose P, Kalus JS. Impact of platelet functional assays on the cost of treating suspected heparin induced thrombocytopenia (HIT). J Pharm Pract 2015;28:398-403.
  • Jennings DL,* Makowski C, Chambers R, Lanfear DE. Dosing of vancomycin in patients With continuous-flow left ventricular assist devices: A clinical pharmacokinetic analysis. Int J Artif Organs 2014;37:270-4.
  • Jennings DL,* Chopra A, Chambers R, Morgan JA. Clinical outcomes associated with chronic antimicrobial suppression therapy in patients with continuous-flow left- ventricular assist devices. Artificial Organs 2014;38:875-879.
  • Lekura J, Williams CT, Tita C, Lanfear DE, Jennings DL.* Assessing the potential of email for communicating drug-therapy recommendations to physicians in patients with heart failure and ventricular-assist devices. J Pharm Pract 2014;27:478-480.
  • Makowski C, Jennings DL, Nemerovski CW, Kalus JS. The impact of pharmacist-directed patient education and anticoagulant care coordination on patient satisfaction. Ann Pharmacother 2013;47:805-10.
  • Jennings DL,* Nemerovski CW, Kalus JK. Effective anticoagulation for a percutaneous ventricular assist device using a heparin-based purge solution. Ann Pharmacother 2013;47:1364–1367.
  • Jennings DL,* Williams CT, Morgan JA. Pentoxifylline for the treatment of hemolytic anemia in a patient who developed recurrent gastrointestinal bleeding while on continuous-flow left-ventricular assist device support. ASAIO J 2013;59:526-7.
  • Jennings DL,* Cabrera R, Wang D, Tita C. Successful treatment of a continuous flow left- ventricular assist device thrombosis with eptifibatide. ASAIO J 2012;58:633–635.
  • Jennings DL,* Brewer R, Williams CT. Impact of continuous flow left-ventricular assist device on the pharmacodynamic response to warfarin early after implantation. Ann Pharmacother 2012;46:1266-7.
  • Jennings DL,* Jones MC, Lanfear DE. Assessment of the heart failure pharmacotherapy of patients with continuous flow left-ventricular assist devices. Int J Artif Organs 2012;35:177-9.
  • Dumkow L, Voss J, Peters M, Jennings DL.* Attempted reversal of a life-threatening dabigatran-related bleed with a prothrombin complex concentrate and fresh frozen plasma. Am J Health Syst Pharm 2012;69:1646-1650.
  • Jennings DL,* Brewer R, Smith C, Williams CT. Clinical Pharmacist Intervention for Patients with Left Ventricular Assist Devices. Ann Pharmacother 2011;45:1311-2.
  • Jennings DL,* McDonnell J, Schillig J. Assessment of the long-term anticoagulation of patients with a continuous flow left-ventricular assist device: A pilot study. J Thorac Cardiovasc Surg 2011;142:e1-e2.
  • Jennings DL,* Nemerovski CW, Khandelwal A. Successful extended use of a percutaneous left-ventricular assist device without a heparin-based purge solution. Am J Health Syst Pharm 2010;67:1825-8.
  • Edwin SB, Jennings DL, Kalus JS. An Evaluation of the Early Pharmacodynamic Response after Simultaneous Initiation of Warfarin and Amiodarone. J Clin Pharmcol 2010;50:693-8. Jennings DL,* Kalus JS. Addition of cilostazol to aspirin and a thienopyridine for prevention of restenosis after coronary artery stenting: A meta-analysis. J Clin Pharmacol 2010;50:415-21.
  • Jennings DL,* Taber D. Utilizing Inhibitors of the Renin-Angiotensin System Early After Renal Transplant. Ann Pharmacother 2008;42:116-20.
  • Hansen L, Jennings DL, Pallares MJ, Thompson A, Garrison K, Wessell AM. Assessment of vitamin K use in the inpatient treatment of excessive anticoagulation. J Pharm Technol 2008;24:137-41.
  • Jennings DL, Coleman CI, Kalus JS. Combination therapy with an ACE inhibitor and an angiotensin receptor blocker for diabetic nephropathy: A meta-analysis. Diabet Med 2007;24:486–493.
  • Jennings DL, Ragucci KR, Chumney E, Wessell A. Impact of Pharmacist Intervention on Diabetes Related Quality of Life in an Ambulatory Care Clinic. Pharmacy Practice 2007;5:169-173.
  • Jennings DL, Yagman LA, Petricca JC, O’Dell K, Kalus JS. Predictors of early readmission after acute coronary syndrome. Am J Health Syst Pharm 2006;15;63:367-72.

Reviews & Commentary

  • Lange NW, Salerno DM, Jennings DL, Choe J, Hedvat J, Bley Kovac D, Scheffert J, Shertel T, Ratner LE, Brown RS Jr, Pereira MR. Nirmatrelvir/ritonavir use: Managing clinically significant drug-drug interactions with transplant immunosuppressants. Am J Transplant 2022;22(7):1925-1926.
  • Ventura D, Carr AL, Davis RD, Silvestry S, Bogar L, Raval N, Gries C, Hayes JE, Oliveira E, Sniffen J, Allison SL, Herrera V, Jennings DL, Page RL 2nd, McDyer JF, Ensor CR. Renin Angiotensin Aldosterone System Antagonism in 2019 Novel Coronavirus Acute Lung Injury. Open Forum Infect Dis 2021 Apr 4;8(10):ofab170.
  • Beavers CJ, DiDomenico RJ, Dunn SP, Cox J, To L, Weeks P, Trujillo TC, Jennings DL. Optimizing Anticoagulation for Patients Receiving Impella Support. Pharmacotherapy 2021;41(11):932-942.
  • Bley D, Choe J, Liu E, Scheffert J, Hedvat J, Anamisis A, Salerno D, Lange N, Jennings DL. Immunosuppression considerations in simultaneous organ transplant. Pharmacotherapy 2021;41:59-76.
  • Hollis IB, Doligalski C, Jennings DL. Pharmacotherapy for durable left ventricular assist devices. Pharmacotherapy2021;41:14-27.
  • Littlefield AJ, Jones G, Ciolek AM, Yuzefpolskaya M, Jennings DL.* A reappraisal of the pharmacologic management of gastrointestinal bleeding in patients with continuous flow left ventricular assist devices. Heart Fail Rev 2021;26:277-288.
  • Jennings DL, Rismans J, Connors JM. Prothrombin complex concentrate for warfarin reversal in patients with continuous-flow left ventricular assist devices: A narrative review. ASAIO J 2020;66:482-488.
  • Truby LK, DeRoo S, Spellman J, Jennings DL, Takeda K, Fine B, Restaino S, Farr M. Management of primary graft failure after heart transplantation: Preoperative Risks, perioperative events, and postoperative decisions. Clin Transplant 2019;33:e13557.
  • Ciolek AM, Littlefield AJ, Jennings DL.* Engineering a Brighter Future: The Evolving Role of the Pharmacist in the Era of the HeartMate 3. Ann Pharmacother 2019;53:430-433.
  • Jennings DL.* Increase in short-term of rejection in heart transplant patients receiving granulocyte colony-stimulating factor. J Heart Lung Transplant 2018;37:1475.
  • Jackevicius CA, Page RL, Buckley LF, Jennings DL, Nappi JM, Smith AJ. Key Articles and Guidelines in the Management of Heart Failure: 2018 Update. J Pharm Pract 2019;32:77-92.
  • Jennings DL,* Lange N, Shullo M, Baker WL. Mammalian Target of Rapamycin Inhibitors and Survival in Heart Transplant Recipients: Miracle or Mirage? J Am Coll Cardiol 2018;71:2859-60.
  • Lee CL, Eisenberger AB, Jennings DL, Takayama H. Abciximab/Heparin During Acute Heparin-induced Thrombocytopenia: A Word of Caution (Reply). Ann Thorac Surg 2018; 106:309-10.
  • Jennings DL.* Heart Failure Therapy in 2016: SHIFTing the PARADIGM From Antiquated Therapies Toward Novel Agents. Ann Pharmacother 2017;51:79-82.
  • Jennings DL.* Letter by Jennings Regarding Article, “Stroke Risk and Mortality in Patients With Ventricular Assist Devices.” Stroke2017;48:e26.
  • Sabato LA, Salerno DM, Moretz JD, Jennings DL.* Inhaled pulmonary vasodilator therapy for management of right-ventricular dysfunction after left ventricular assist device placement and cardiac transplantation. Pharmacotherapy 2017;37:944-955.
  • Allender JE, Reed BN, Foster JL, Moretz JD, Oliphant CS, Jennings DL, DiDomenico RJ, Coons JC. Pharmacologic Considerations in the Management of Patients Receiving Left Ventricular Percutaneous Mechanical Circulatory Support. Pharmacotherapy 2017;37:1272–1283.
  • Sieg A, Moretz JD, Horn E, Jennings DL. Pharmacotherapeutic Management of Gastrointestinal Bleeding in Patients with Continuous-Flow Left-Ventricular Assist Devices. Pharmacotherapy 2017;37:1432–1448.
  • Doligalski CT, Jennings DL.Device-Related Thrombosis in Continuous- Flow Left Ventricular Assist Device Support. J Pharm Pract 2016;29:58-66.
  • Jennings DL,* Martinez B, Montalvo S, Lanfear DE. Impact of pre-implant amiodarone exposure on outcomes in cardiac transplant recipients. Heart Fail Rev 2015;20:573-8.
  • Hollis IB, Jennings DL, Oliphant CS, Baker WL, Davis EM, Allender JE, Zemrak WR, Ensor CE. Key Articles and Guidelines in the Management of Patients Undergoing Cardiac Surgery. J Pharm Pract 2015;28:67-85.
  • Jennings DL,* Weeks P. Thrombosis in continuous-flow left-ventricular assist devices: Pathophysiology,preventionandpharmacologicmanagement. Pharmacotherapy 2015;35:79–98.
  • Jennings DL.* The ”doctors” will see you now: A pharmacist’s take on the ”Truth in advertising” campaign. Ann Pharmacother 2015;49:127-129.
  • Jennings DL,* Miyares MA. Clinical outcomes with beta-blockers after myocardial infarction: Finding the right patient and the right regimen. Am J Med 2014;127:e17.
  • Jennings DL.* Letter by Jennings Regarding Article, “Mechanisms of Bleeding and Approach to Patients With Axial-Flow Left Ventricular Assist Devices.” Circ Heart Fail 2012;5:e102.
  • Nemerovski CW, Dorsch MP, Jennings DL.What should we be fine tuning in acute coronary syndromes – dosing of antiplatelet therapy or data presentation? Ann Pharmacother 2011;45:120-2.
  • Jennings DL,* Schillig J, Chambers R. The Pharmacotherapy of the HeartMate II, a Continuous Flow Left-ventricular Assist Device, in Patients with Advanced Heart Failure: Integration of Disease, Device and Drug. Ann Pharmacother 2010;44:1647-1650.
  • Jennings DL,* Thompson ML. Use of Combination Therapy with a Beta-blocker and a Positive Inotrope in Patients with Advanced Heart Failure. Ann Pharmacother 2009;43:1872-1876.
  • Jennings DL,* Kalus JS. Focus on Tolvaptan: A novel oral vasopressin V2 receptor antagonist for the treatment of acute decompensated heart failure and hyponatremia. Formulary 2008;4:236-249.
  • Jennings DL, Kalus JS,O’Dell K. Aldosterone Receptor Antagonism in Heart Failure. Pharmacotherapy 2005;25:1126-33.

Book Chapters

  • Jennings DL. Cardiac Transplantation and Mechanical Circulatory Support. In: Baker WL, Beavers C, Bolesta S, et al., eds. Updatesin Therapeutics®: Cardiology Pharmacy Preparatory Review Course, 2021 ed. Lenexa,KS: American Collegeof Clinical Pharmacy,2022: 433-776.
  • Lange NW, Salerno D, Jennings DL. Solid-organ Transplantation. In: Dipiro JT, Yee GA, eds. Pharmacotherapy: A Pathophysiologic Approach, 12th ed. McGraw Hill Medical, New York, NY 2022:1457-1480.
  • Jennings DL. Cardiac Transplantation and Mechanical Circulatory Support. In: Baker WL, Beavers C, Bolesta S, et al., eds. Updatesin Therapeutics®: Cardiology Pharmacy Preparatory Review Course, 2021 ed. Lenexa,KS: American Collegeof Clinical Pharmacy,2021: 433-776.
  • Jennings DL, Johnson H. Solid-organ Transplantation. In: Dipiro JT, Yee GA, eds. Pharmacotherapy: A Pathophysiologic Approach, 11th ed. McGraw Hill Medical, New York, NY 2020:1473-1496.
  • Ciolek AM, Jennings DL.Heart Transplantation. In: Jackevicius C, Patterson JH, eds. Cardiology Self-Assessment Program, 2020 Book 1. Critical Care Cardiology. Lenexa, KS: American College of Clinical Pharmacy, 2020:151-174.
  • Jennings DL, Week P. Advanced Heart Failure: Mechanical Circulatory Support and Heart Transplantation. In: Jackevicius C, Patterson JH, eds. Cardiology Self-Assessment Program, 2019 Book 1. Heart Failure. Lenexa, KS: AmericanCollege of ClinicalPharmacy, 2019:7-31.
  • Jennings DL. Cardiac Transplantation and Mechanical Circulatory Support. In: Baker WL, Beavers C, Bolesta S, et al., eds. Updatesin Therapeutics®: Cardiology Pharmacy Preparatory Review Course, 2019 ed. Lenexa,KS: American Collegeof Clinical Pharmacy,2019: 433-776.
  • Jennings DL, Ensor CR. Cardiac Transplantation and Mechanical Circulatory Support for Advanced Heart Failure. In: Baker WL, Beavers C, Bolesta S, et al., eds. Updates in Therapeutics®: Cardiology Pharmacy Preparatory ReviewCourse, 2018 ed. Lenexa, KS: American College of Clinical Pharmacy, 2018:401-44.

Lectures and Presentations

  • “Nothing works without the engine running: update on ADVANCED heart failure management.” ISHLTv Webinar Series from the Advanced Heart failure management." ISHLTv Webinar Series from the Advanced Heart Failure and Transplantation Interdisciplinary Network, February 2023.
  • “Update in Heart Failure DrugTherapy.” American College of Cardiology Middle East Together With 13th Emirates Cardiac Society Congress.Dubai, UAE. October 2022.
  • “From Bedside to Breakthrough: Driving Innovation Through Practice-based Research.” Honorary Tracey Shannon Lecture for the American Collegeof Cardiology New York State Chapter Cardiovascular Team Section summer meeting. New York, NY. June 2022.
  • “Gut Microbiota and Metabolism of Immunosuppressive Drugs: One Size Does Not Fit All.” International Societyof Heart and Lung Transplantation Annual Meeting, Boston,MA. April 2022.
  • “Pondering Anticoagulation Options in Mechanical Assist Devices.” American College of Cardiology Annual Scientific Sessions, Washington, DC. April2022.
  • “Heart Failure Medical Therapy in 2021: How does this apply to my LVAD patient?” ISHLTv Webinar Seriesfrom the Mechanical Circulatory Support Interdisciplinary Network, November 2021.
  • “Contemporary trends in antithrombotic therapy for LVADs.” Frontiers in Heart Failure in 2021: Applying Science into Clinical Practice, Sao Paolo, Brazil (held virtually), September 2021.
  • “They Still Have A Failing Heart, Max GDMT for All!” Heart Failure Society of America Annual Meeting, Denver, CO. September 2021.
  • “Professional and Leadership Development.” American Society of Health-system Pharmacists Annual Midyear Clinical Meeting, December 2020 (held virtually).
  • “Time for a Tune Up: Let the Pharmacist Under the Hood Before you Hit the Road.” Heart Failure Society of America Annual Meeting, September, 2020 (held virtually).
  • “Should mTOR inhibitors Have a Prominent Role in Immunosuppression Regimens After Heart Transplantation? ” American College of Clinical Pharmacy Annual Meeting, New York, NY. October 2019.
  • “Pharmacologic Considerations in Heart Failure Patients with End-stage Kidney Disease.” Heart Failure Society of America Annual Meeting, Philadelphia, PA. September 2019.
  • “Considerations in Anticoagulation and Antiplatelet Therapy in LVAD Patients.” Heart Failure Society of America Annual Meeting, Philadelphia, PA. September 2019.
  • “The Opioid Epidemic: Implications for Organ Donation.” AMA Accredited Continuing Education Presentation. CATCH-UP 2019: Heart Failure, Devices, and Interventions. New York Presbyterian Columbia University Medical Center. April 2019.
  • “Lipid Management Challenges and Strategies in Transplant Recipients.” The American Transplant Congress, Boston, MA. May 2019.
  • “Time in Therapeutic Range: Is There an Optimal Way to Manage INR?” International Society of Heart and Lung Transplantation Annual Meeting, Orlando, FL. April 2019.
  • “Perfecting Your Poster Presentations.” ACCP Annual Meeting, Seattle, WA. October 2018.
  • “Pharmacotherapy Considerations in Heart Failure Patients at the End of Life.” Heart Failure Society of America Annual Meeting, Nashville, TN. September 2018.
  • “Addressing Diagnostic and Therapeutic Challenges in Pulmonary Arterial Hypertension through Pharmacist Intervention.” Pharmacy Learning Network Regional Meeting, Philadelphia, PA. May 2018.
  • “Solid Organ Transplant and Clinical Pharmacists: Giving Patients a Second Chance at Life.” 3rd Convention of the Indian Association of Colleges of Pharmacy. Hyderabad, India. May 2018.
  • “Cardiotoxicity in Cancer: The Frontier Beyond Anthracyclines.” International Society of Heart and Lung Transplantation Annual Meeting, Nice, France. April 2018.
  • “Addressing Diagnostic and Therapeutic Challenges in Pulmonary Arterial Hypertension through Pharmacist Intervention.” Pharmacy Learning Network Regional Meeting, Tampa, FL. March 2018.
  • “An On Going Challenge : How to Improve Safe Management of Anticoagulation During Pregnancy.” American College of Cardiology Annual Scientific Session and Expo, Orlando, FL. March 2018.
  • “Ramifications of Antibiotic Prophylaxis Guidelines for Endocarditis Prophylaxis.” American College of Cardiology Annual Scientific Session and Expo, Orlando, FL. March 2018.
  • “Heart Transplant and Mechanical Circulatory Support.” Updates in Therapeutics® 2018: Cardiology Pharmacy Preparatory Review Course. ACCP Meeting in Jacksonville, FL. February 2018.
  • “Initiating and Monitoring of Anticoagulation.” AMA Accredited Continuing Education Presentation. CATCH-UP 2017: Heart Failure, Devices, and Interventions. New York Presbyterian Columbia University Medical Center. April 2017.
  • “Is Cangrelor the New CHAMPION for Antiplatelet Therapy during Percutaneous Coronary Intervention?” ASHP Midyear Clinical Meeting, Las Vegas, NV. December 2016.
  • “Cardiogenic Shock and Mechanical Circulatory Support for Advanced Heart Failure.” Clinical Reasoning Series at the ACCP Annual Meeting, Fort Lauderdale, FL. October 2016.
  • “New Treatments for an Old Disease: Updates in Heart Failure Management.” New York State Council of Heath-system Pharmacists Long Island Chapter. September 2016.
  • “Optimizing Thromboprophylactic Strategies in Durable Mechanical Circulatory Support Devices. ” Cardiology Grand Rounds, University of Nebraska Hospital. September 2016.
  • “Pre-operative Genetic Screening for Coagulation Abnormalities and Impact on Post- operative Management.” International Society of Heart and Lung Transplantation Annual Meeting, Washington, DC. April 2016.
  • “Initiating and Monitoring of Anticoagulation.” AMA Accredited Continuing Education Presentation. CATCH-UP 2016: Heart Failure, Devices, and Interventions. New York Presbyterian Columbia University Medical Center. March 2016.
  • “Diuretic Actions, Thresholds, Combinations, and Myths.” American College of Cardiology Annual Scientific Session and Expo, Chicago, IL. March 2016.
  • “New Treatments for an Old Disease: Updates in Heart Failure Management.” New York State ACCP Chapter Annual Meeting, Albany College of Pharmacy. November 2015.
  • Pharmacy Learning Network Regional Meeting, Washington, DC. October 2015.
  • “Optimizing Outcomes with Oral Antiplatelet Therapies in ACS and Secondary Prevention.”
  • Pharmacy Practice Module – Advanced Learning Series 3: “Pharmacotherapy of Heart Failure.” Puspagiri College of Pharmacy/Indian Association of Colleges of Pharmacy; Tiruvalla, Kerala, India. August 2015.
  • Pharmacy Practice Module – Advanced Learning Series 3: “Pharmacotherapy of Atrial Fibrillation.” Puspagiri College of Pharmacy/Indian Association of Colleges of Pharmacy; Tiruvalla, Kerala, India. August 2015.
  • Pharmacy Practice Module – Advanced Learning Series 3: “Pharmacotherapy of Acute Coronary Syndromes.” Puspagiri College of Pharmacy/Indian Association of Colleges of Pharmacy; Tiruvalla, Kerala, India. August 2015.
  • “Optimizing Outcomes with Oral Antiplatelet Therapies in ACS and Secondary Prevention.” Pharmacy Learning Network Regional Meeting, Orlando, FL. May 2015.
  • “The Beta Adrenergic Receptor Post-MI: Beta-Blocker Use Should Stop.” American College of Cardiology Annual Scientific Session and Expo, San Diego, CA. March 2015.
  • “Optimizing Outcomes with Oral Antiplatelet Therapies in ACS and Secondary Prevention.” Pharmacy Learning Network Regional Meeting, San Mateo, CA. March 2015.
  • ASHP Advantage Continuing Education Series: Overcoming Challenges in Acute Coronary Syndrome - Case Studies in ACS Management: “Perioperative Management” and “Management of Bleeding from Antiplatelet Therapy.” ASHP Midyear Clinical Meeting, Anaheim CA. December 2014.
  • “Optimizing Anticoagulation in Patients with Durable Mechanical Circulatory Support Devices.” ASHP Midyear Clinical Meeting, Anaheim, CA. December 2014.
  • “Anticoagulation Management During Mechanical Circulatory Support.” Advanced Heart Failure Symposium American Association of Heart Failure Nurses, Tampa, FL. February 2014.
  • “What’s New with Stable Ischemic Heart Disease?” The Larry Lopez Cardiovascular Seminar: Redefining and Refining the Treatment Approaches to Cardiovascular Disease, Orlando, Florida. October 2014.
  • “Hypertension Guidelines and Treatment Challenges.” 25th Annual Contemporary Pharmacy Issues Seminar, Ft. Lauderdale, FL. May 2014.
  • Pharmacy Practice Module – Advanced Learning Series 3: “Pharmacotherapy of Atrial Fibrillation.” Shri Vishnu College of Pharmacy/Indian Association of Colleges of Pharmacy; Vishnupur, Bhimavaram, West Godavari Dist, Andhra Pradesh, India. March 2014.
  • Pharmacy Practice Module – Advanced Learning Series 3: “Pharmacotherapy of Heart Failure.” Shri Vishnu College of Pharmacy/Indian Association of Colleges of Pharmacy; Vishnupur, Bhimavaram, West Godavari Dist, Andhra Pradesh, India. March 2014.
  • Pharmacy Practice Module – Advanced Learning Series 3: “Pharmacotherapy of Ischemic Heart Disease.” Shri Vishnu College of Pharmacy/Indian Association of Colleges of Pharmacy; Vishnupur, Bhimavaram, West Godavari Dist, Andhra Pradesh, India. March 2014.
  • “Pharmacotherapy of Patients with Long-term Mechanical Circulatory Support for End-stateHeart Failure.” ACCP Annual Meeting, Albuquerque, NM. October 2013.
  • 2nd International Cardiovascular Pharmacotherapy Conference: “Combined Atrial Fibrillation and Heart Failure: Challenges in Pharmacotherapy Management.” Prince Sultan Cardiac Center, Pharmacy Department, Riyadh, Saudi Arabia. April 2012.
  • 2nd International Cardiovascular Pharmacotherapy Conference: “Strategies for Managing Resistant Hypertension.” Prince Sultan Cardiac Center, Pharmacy Department, Riyadh, Saudi Arabia. April 2012.
  • 2nd International Cardiovascular Pharmacotherapy Conference: “Devices and Technology in the Management of Heart Failure.” Prince Sultan Cardiac Center, Pharmacy Department, Riyadh, Saudi Arabia. April 2012.
  • ASHP Advantage Continuing Education Series: “Update on Stroke Prevention in Atrial Fibrillation.” Oklahoma Society of Health-System Pharmacist Annual Meeting, Tulsa OK. March 2012.
  • ASHP Advantage Continuing Education Series: “Considerations for the Prevention of Stroke in Atrial Fibrillation.” Pharmacy Society of Wisconsin Education Conference, Madison WI. April 2011.
  • “Strategies for Rhythm Control in Atrial Fibrillation.” Mid-Atlantic College of Clinical Pharmacy Meeting, Philadelphia, PN. September 2010.

Scientific Abstracts & Conference Papers

  • Topkara VK, Garan AR, Yuzefpolskaya M, Takeda K, Takayama H, Fried JA, Wong K, Jennings DL, Te-Frey R, Haythe J, Maurer M, Farr MA, Mancini DM, Naka Y, Colombo PC. Changes in Lipid Profile Subfractions on CF-LVAD Support. Poster: ISHLT 36th Annual Meeting and Scientific Sessions, Washington, DC Abstract published: Journal of Heart and Lung Transplantation, 2017
  • Colombo PC, Jennings DL,Garan AR, Yuzefpolskaya M, Takeda K, Takayama H, Castagna F, Maurer M, Zorn E, Latif F, Restaino S, Farr MJ, Naka Y, Mancini DM, Topkara VK. Alloantibody Desensitization Therapy in BTT Patients on LVAD Support. Poster: ISHLT 36th Annual Meeting and Scientific Sessions, Washington, DC Abstract published: Journal of Heart and Lung Transplantation, 2017
  • Colombo PC, Yuzefpolskaya M, Jennings DL, Willey JZ, Flannery M, Cagliostro B, Garan AR, Naka Y, Takayama H, Takeda K, Castagna F, Mancini DM, Eisenberger AB, Topkara VK. Usefulness of a Multipronged Strategy to Prevent Device Thrombosis in HeartMate II Left Ventricular Assist Devices. Poster: ISHLT 36th Annual Meeting and Scientific Sessions, Washington, DC Abstract published: Journal of Heart and Lung Transplantation, 2017
  • Kuyumjian YM, Leverock J, Miyares MA, Bednar B, Chaparro S, Panos A, Baker WL, Jennings DL. A multidisciplinary team-based process improves anticoagulation quality in patients with continuous-flow left-ventricular assist devices. Oral Presentation: ISHLT 36th Annual Meeting and Scientific Sessions, Washington, DC Abstract published: Journal of Heart and Lung Transplantation, 2017
  • Jennings DL, Garan AR, Yuzefpolskaya M, Takeda K, Takayama H, Mancini DM, Naka Y, Colombo PC, Topkara VK. Genotype-guided Warfarin Dosing in Continuous-flow Left- ventricular Assist Device (CF-LVAD) Patients. Mini Oral : ISHLT 36th Annual Meeting and Scientific Sessions, Washington, DC Abstract published: Journal of Heart and Lung Transplantation, 2017
  • Jennings DL, Baker WL. Pre-Transplant Amiodarone Exposure Increases Mortality in Cardiac Transplant Recipients: A Meta-Analysis. Poster: ISHLT 36th Annual Meeting and Scientific Sessions, Washington, DC Abstract published: Journal of Heart and Lung Transplantation, 2017
  • Jennings DL, Horn E, Lyster H, Panos A, Teuteberg JJ, Lehmkuhl HB, Wolowich W, Shullo M. Assessing Anticoagulation Practice Patterns in Patients on Durable Mechanical Circulatory Support Devices: An International Survey. Oral Presentation: ISHLT 35th Annual Meeting and Scientific Sessions, Nice, France Abstract published: Journal of Heart and Lung Transplantation, 2016
  • To L, Nemerovski CW, Kalus JS, Jennings DL.Readmission rates in patients with post- operative atrial fibrillation after cardiothoracic surgery and the impact of pharmacotherapy. Poster: ACCP Annual Meeting, Austin, TX. Abstract Published: Pharmacotherapy, 2015
  • Jennings DL, Wagner JL, Nemerovski CW, Kalus JS, Morgan JA, Lanfear DE. Epidemiology and Outcomes Associated With Anemia During Long-Term Continuous-Flow Left Ventricular Assist Device Support. Poster: ISHLT 34th Annual Meeting and Scientific Sessions, San Diego, CA Abstract published: Journal of Heart and Lung Transplantation, 2015
  • Jennings DL, Jacob M, Chopra A, Nemerovski CW, Morgan JA, Lanfear DE. Safety of Anticoagulation Reversal in Patients Supported With Continuous-Flow Left-Ventricular Assist Devices. Poster: ISHLT 34th Annual Meeting and Scientific Sessions, San Diego, Abstract published: Journal of Heart and Lung Transplantation, 2015
  • Jennings DL, Gellatly RM, Szandzik E, Leet A, Lanfear DE. Anticoagulation for the HeartWare HVAD: An International Comparison of Strategies and Outcomes. Poster: ISHLT, 34th Annual Meeting and Scientific Sessions, San Diego, CA Abstract published: Journal of Heart and Lung Transplantation, 2015
  • Jennings DL, Arter A, Morgan JA, Lanfear DE. Defining the Dose Response of Oral Sildenafil in Patients with Advanced Heart Failure. Poster: ACCP annual Meeting, Albuquerque, NM. Abstract Published: Pharmacotherapy, 2014
  • Kansagra J, Bryant M, Jennings D, Lanfear DE, Tita C, Brewer R, Morgan JA, Nemeh H, Williams C. Incidence and Associated Variable Cost of Hospital Readmission during Long- Term Continuous Flow Left Ventricular Assist Device (CF-LVAD) Implantation. Poster: Heart Failure Society of America Annual Scientific Meeting, Orlando, FL Abstract Published: Journal of Cardiac Failure, 2014
  • Jennings DL, Brewer R, Williams CT, Morgan JA. Impact of pre-operative ACE inhibitor exposure on the incidence of intraoperative and postoperative refractory vasoplegia in patients undergoing left-ventricular assist device implantation. Oral Presentation: ASAIO 59th Annual Meeting, Chicago, IL, Abstract Published: ASAIO Journal, 2014
  • Jennings DL, Chopra A, Chambers R, Williams CT, Morgan JA. Outcomes of chronic antimicrobial suppression therapy in patients with previous infection on continuous flow left ventricular device support. Poster: ASAIO 59th Annual Meeting, Chicago, IL, Abstract Published: ASAIO Journal, 2014
  • Jennings DL, Smith C, Williams CT. Use of pentoxiphylline for hemolytic anemia in a patient with a continuous-flow left-ventricular assist device. Poster: International Society of Heart and Lung Transplantation (ISHLT), 33rd Annual Meeting and Scientific Sessions, Montreal, Ca. Abstract published: Journal of Heart and Lung Transplantation, 2014
  • To L, Kalus JK, Nemerovski CW, Jennings DL. Rates of readmission in patients with post- operative atrial fibrillation after cardiothoracic surgery. Poster: ASHP Midyear Clinical Meeting, Las Vegas, NV. 12/2013
  • Jennings DL, Lekura J. Ability of a clinical pharmacist to make drug therapy interventions using email in patients with advanced heart failure and ventricular-assist devices. Poster: ACCP Annual Meeting, Hollywood, FL. Abstract published: Pharmacotherapy, 2013
  • Jennings DL, Sadik Z, Nemerovski CW, Kalus JS. Impact of platelet functional assays on the cost of treating suspected heparin induced thrombocytopenia (HIT). Poster: ACCP Annual Meeting, Hollywood, FL. Abstract published: Pharmacotherapy, 2013
  • Makowski CT, Chamber R, Jennings DL.Pharmacokinetics of vancomycin in patients with continuous flow left-ventricular assist devices. Poster: ACCP Annual Meeting, Hollywood, FL. Abstract published: Pharmacotherapy, 2013
  • Makowski CT, Jennings DL, Nemverovski CW, Kalus JS. Patient satisfaction with an inpatient pharmacist-directed anticoagulation service. Poster: ACCP Annual Meeting, Hollywood, FL. Abstract published: Pharmacotherapy, 2013
  • Williams CT, Jennings DL, Karadolian S, Chamaria S. Analysis of cost for readmissions after continuous flow left ventricular assist device implantation: A single center experience. Oral Presentation: American College of Cardiology Scientific Session, Chicago, IL. Abstract published: J Am Coll Cardiol 2012;59(13):E1018.
  • Jennings DL, Smith C, Brewer B, Williams CT. Opportunities for clinical pharmacist intervention in pharmacotherapy of patients with left-ventricular assist devices. Oral Presentation: ACCP Annual Meeting, Pittsburgh, PA. Abstract published: Pharmacotherapy, 2012
  • Jennings DL, Brewer B, Williams CT. Left-ventricular assist device implantation does not alter the pharmacodynamic response to warfarin. Poster: ACCP Annual Meeting, Pittsburgh, PA. Abstract published: Pharmacotherapy, 2012
  • Chamaria S, Jennings DL, Williams C. Initial clinical experience with oral sildenafil in patients with elevated pulmonary artery pressure after implantation of newer left- ventricular assist devices. Poster: American Society for Artificial Internal Organs Annual (ASAIO) Conference, Washington, DC. 06/2012
  • Jones M, Lanfear D, Jennings DL. Assessment of the heart failure pharmacotherapy of patients with continuous, axial‐flow left‐ventricular assist devices. Poster: ASHP Midyear Clinical Meeting, Anaheim, Ca. 12/2011
  • Smith Z, Jennings DL. Pharmacotherapy of patients with ST-segment elevation myocardial infarction undergoing rescue percutaneous coronary intevention. Poster: ASHP Midyear Clinical Meeting, Anaheim, Ca. 12/2011
  • Wong J, Lulek K, Jennings DL, Nemerovski CW, Kalus JS. Assessment of antiplatelet and anticoagulant use in the cardiac catheterization laboratory. Poster: ASHP Midyear Clinical Meeting, Anaheim, Ca. 12/2011
  • Jennings DL, McDonnell J, Schillig J. Evaluation of long-term anticoagulation in patients with left-ventricular assist devices. Poster: ACCP Annual Meeting in Austin, TX. Abstract Published: Pharmacotherapy, 2011
  • Jennings DL, Kheiri A, Kalus JS. An evaluation of employers’ perceptions on the value of a pharmacy resident teaching certificate program. Poster: ACCP Annual Meeting in Austin, TX. Abstract Published: Pharmacotherapy, 2011
  • Gross A, Jennings DL, Fleming J, Davis S. Healthcare Associated Infection in Patients with Left Ventricular Assist Devices. Poster: The 50th annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Boston, MA. 09/2011
  • Ma M, Jennings DL, Kalus JS. Hemodynamic and electrocardiographic effects of short-term cyanocobalamin administration on healthy volunteers. Poster: ASHP Midyear Meeting in Las Vegas, NV. 12/2010
  • Jennings DL, Kalus JS. Addition of cilostazol to aspirin and a thienopyridine for prevention of restenosis after coronary artery stenting: A meta-analysis. Oral Presentation: American Heart Association Scientific Sessions, New Orleans, LA. 11/2008 Abstract Published: Circulation, 2009
  • Jennings DL, Hansen L, Pallares MJ, Thompson A, Garrison K, Wessell AM. Assessment of Vitamin K Use in the Inpatient Treatment of Excessive Anticoagulation. Poster: American College of Clinical Pharmacy (ACCP) Annual Meeting, Denver, CO. 12/2007 Abstract Published: Pharmacotherapy, 2008
  • Jennings DL, Ragucci KR.Diabetes Quality of Life in an Ambulatory Care Clinic. Poster: University Health system Consortium, in conjunction with the American Society of Health-System Pharmacists Midyear Clinical Meeting in Anaheim, CA. 12/2007
  • Manierski C, Jennings DL, Kalus JS. Combination therapy with an ACE inhibitor and an angiotensin receptor blocker for diabetic nephropathy: A Meta-Analysis. Oral Presentation: American Society of Nephrology Renal Week in Philadelphia, PN. Abstract Published: J Am Soc Nephrol, 2006
  • Yagman LA, Petricca JC, Jennings DL, O’Dell K, Kalus JS. A Pilot Study to Evaluate Whether Patient Factors Predict Early Readmission After Acute Coronary Syndromes. Poster: American Society of Health-system Pharmacy (ASHP) Midyear Meeting, Orlando, FL Abstract Published: Am J Health-Syst Pharm, 2005
  • Givens RC, Topkara VK, Edmondson D, Restaino S, Colombo PC, Latif F, Jennings D, Naka Y, Taykayma N, Takeda, K, Farr M. Predictors and Outcomes of Readmission After Heart Transplantation: An Analysis of UNOS/OPTN Data From 2000 to 2015. Poster: ISHLT 38th Annual Meeting and Scientific Sessions, Nice, France Abstract published: Journal of Heart and Lung Transplantation, 2018
  • Wright N, Takeda K,Mauro C, Jennings DL, Kurlansky P, Han J, Truby L Stein S, Topkara V,1 Garan AR, Yuzefpolskaya M, Colombo P, Naka Y, Farr M, Takayama H. Dose-Dependent Association Between Amiodarone and Primary Graft Dysfunction in Heart Transplantation. Poster: ISHLT 37th Annual Meeting and Scientific Sessions, San Diego, CA Abstract published: Journal of Heart and Lung Transplantation, 2017
  • Lee C, Colombo PC, Jennings D, Han J, James MB, Wright MA, Takeda K, Kurlansky PA, Yuzefpolskaya M, Garan AR, Chan C, Naka Y, Takayama H. Use of Abciximab and Heparin Can Safely Facilitate LVAD Implantation in Patients with Heparin-Induced Thrombocytopenia. Poster: ISHLT 37th Annual Meeting and Scientific Sessions, San Diego, CA Abstract published: Journal of Heart and Lung Transplantation, 2017
  • Breslin N , Salerno D, Jandovitz N, Tsapepas D, Restaino S, Latif F, Colombo P, Farr M, Jennings DL. Tacrolimus Dosing Requirements Are Reduced in Heart Transplant Recipients with Severe Primary Graft Dysfunction on ECMO Support. Oral Presentation: ISHLT 37th Annual Meeting and Scientific Sessions, San Diego, CA Abstract published: Journal of Heart and Lung Transplantation, 2017
  • Jennings DL, Yuzefpolskaya M, Garan AR, Eisenberger A, Takeda K, Takayama H, Naka Y, Colombo P, Topkara V. A Genotype Guided Warfarin Protocol Improves Anticoagulation Quality Early After LVAD Implantation. Mini-Oral: ISHLT 37th Annual Meeting and Scientific Sessions, San Diego, CA Abstract published: Journal of Heart and Lung Transplantation, 2017
  • Pennoyer A, Jennings DL, Patel A, Kirtane A, Ma K. Intracoronary nicardipine as a safe and cost-effective alternative to nitroprusside for slow- or no-reflow during percutaneous coronary intervention. Poster: ACCP Annual Meeting, Hollywood, FL 10/16 Abstract published: Pharmacotherapy 2016
  • Topkara VK, Eisenberger AB, Jennings DL, Garan AR, Yuzefpolskaya M, Takeda K, Takayama H, Ton KV, Maurer M, Mancini DM, Naka Y, Colombo PC. Relationship of Factor II and Factor X Activity with INR in CF- LVAD Patients: A Cross-Sectional Study. Oral Presentation : ISHLT 36th Annual Meeting and Scientific Sessions, Washington, DC Abstract published: Journal of Heart and Lung Transplantation, 2016
  • Garan AR, Mai X, Topkara VK, Clerkin KJ, Wong K, Castagna F, Trinh PN, Sreekanth S, Jennings DL, Torres MF,Cagliostro B, Parkis G, Takeda K, Takayama H, Naka Y, Maurer M, Mancini DM, Yuzefpolskaya M, Dizon JM, Colombo PC. QRS Duration Predicts Outcomes Following Implantation of a Left Ventricular Assist Device. Poster: ISHLT 36th Annual Meeting and Scientific Sessions, Washington, DC Abstract published: Journal of Heart and Lung Transplantation, 2016
  • Garan AR, Topkara VK, Mai X, Varr BC, Wong K, Tiburcio M, Flannery M, Jennings DL, Takeda K, Takayama H, Naka Y, Maurer M, Mancini DM, Yuzefpolskaya M, Whang W, Colombo PC. Arrhythmia History Predicts Morbidity and Mortality Following LVAD. Poster: ISHLT 36th Annual Meeting and Scientific Sessions, Washington, DC Abstract published: Journal of Heart and Lung Transplantation, 2016
  • Wong K, Topkara VK, Castagna F, Trinh PN, Sreekanth S, Jennings DL, Te-Frey R, Takeda K, Takayama H, Naka Y, Maurer M, Mancini D, Yuzefpolskaya M, Colombo PC, Garan AR. Electrical Remodeling After Continuous-Flow Left Ventricular Assist Device Implantation. Oral Presentation: ISHLT 36th Annual Meeting and Scientific Sessions, Washington, DC Abstract published: Journal of Heart and Lung Transplantation, 2016
  • Topkara VK, Eisenberger AB, Garan AR, Jennings DL, Yuzefpolskaya M, Takeda K, Takayama H, Castagna F, Cagliostro B, Flannery M, Te-Frey R, Uryevick Al, Latif F, Maurer M, Farr MA, Mancini DM, Naka Y, Colombo PC. Aspirin Responsiveness Predicts Mucosal Bleeding Events in Patients with Continuous-Flow Left Ventricular Assist Devices. Oral Presentation: ISHLT 36th Annual Meeting and Scientific Sessions, Washington, DC Abstract published: Journal of Heart and Lung Transplantation, 2016
  • Topkara VK, Garan AR, Ton KV, Yuzefpolskaya M, Takeda K, Takayama H, Jennings DL, Castagna F, Cagliostro B, Farr MA, Maurer M, Mancini DM, Naka Y, Colombo PC.Red Cell Distribution Width (RDW) Predicts 90-Day Mortality in Continuous-Flow Left Ventricular Assist Device (CF-LVAD) Patients. Oral Presentation: ISHLT 36th Annual Meeting and Scientific Sessions, Washington, DC Abstract published: Journal of Heart and Lung Transplantation, 2016
  • Topkara VK, Eisenberger AB, Garan AR, Yuzefpolskaya M, Takeda K, Takayama H, Jennings DL, Givens R, Fried J, Wong K, Torres M, Ross K, Parkis G, Maurer M, Mancini DM, Naka Y, Colombo PC. Hemolysis Does Not Lead to Increased Discordance between Measured APTT and ANTI-XA Levels in Patients with Continuous-Flow Left Ventricular Assist Devices. Oral Presentation: ISHLT 36th Annual Meeting and Scientific Sessions, Washington, DC Abstract published: Journal of Heart and Lung Transplantation, 2016
  • Topkara VK, Eisenberger AB, Knotts R, Jennings DL, Garan AR, Yuzefpolskaya M, Takeda K, Takayama H, Li RC, Fried JA, Castagna F, Cagliostro B, Tiburcio M, Mancini DM, Naka Y, Colombo PC, Jorde UP. Warfarin Sensitive Patients Have Higher Risk of Gastrointestinal Bleeding and Device Thrombosis on Continuous-Flow Left Ventricular Assist Device (CF- LVAD) Support. Oral Presentation: ISHLT 36th Annual Meeting and Scientific Sessions, Washington, DC Abstract published: Journal of Heart and Lung Transplantation, 2016
  • Topkara VK, Garan AR, Yuzefpolskaya M, Takeda K, Takayama H, Fried JA, Wong K, Jennings DL, Te-Frey R, Haythe J, Maurer M, Farr MA, Mancini DM, Naka Y, Colombo PC. Changes in Lipid Profile Subfractions on CF-LVAD Support. Poster: ISHLT 36th Annual Meeting and Scientific Sessions, Washington, DC Abstract published: Journal of Heart and Lung Transplantation, 2016
  • Colombo PC, Jennings DL,Garan AR, Yuzefpolskaya M, Takeda K, Takayama H, Castagna F, Maurer M, Zorn E, Latif F, Restaino S, Farr MJ, Naka Y, Mancini DM, Topkara VK. Alloantibody Desensitization Therapy in BTT Patients on LVAD Support. Poster: ISHLT 36th Annual Meeting and Scientific Sessions, Washington, DC Abstract published: Journal of Heart and Lung Transplantation, 2016
  • Colombo PC, Yuzefpolskaya M, Jennings DL, Willey JZ, Flannery M, Cagliostro B, Garan AR, Naka Y, Takayama H, Takeda K, Castagna F, Mancini DM, Eisenberger AB, Topkara VK. Usefulness of a Multipronged Strategy to Prevent Device Thrombosis in HeartMate II Left Ventricular Assist Devices. Poster: ISHLT 36th Annual Meeting and Scientific Sessions, Washington, DC Abstract published: Journal of Heart and Lung Transplantation, 2016
  • Kuyumjian YM, Leverock J, Miyares MA, Bednar B, Chaparro S, Panos A, Baker WL, Jennings DL. A multidisciplinary team-based process improves anticoagulation quality in patients with continuous-flow left-ventricular assist devices. Oral Presentation: ISHLT 36th Annual Meeting and Scientific Sessions, Washington, DC Abstract published: Journal of Heart and Lung Transplantation, 2016
  • Jennings DL, Garan AR, Yuzefpolskaya M, Takeda K, Takayama H, Mancini DM, Naka Y, Colombo PC, Topkara VK. Genotype-guided Warfarin Dosing in Continuous-flow Left- ventricular Assist Device (CF-LVAD) Patients. Mini Oral : ISHLT 36th Annual Meeting and Scientific Sessions, Washington, DC Abstract published: Journal of Heart and Lung Transplantation, 2016
  • Jennings DL, Baker WL. Pre-Transplant Amiodarone Exposure Increases Mortality in Cardiac Transplant Recipients: A Meta-Analysis. Poster: ISHLT 36th Annual Meeting and Scientific Sessions, Washington, DC Abstract published: Journal of Heart and Lung Transplantation, 2016
  • Jennings DL, Horn E, Lyster H, Panos A, Teuteberg JJ, Lehmkuhl HB, Wolowich W, Shullo M. Assessing Anticoagulation Practice Patterns in Patients on Durable Mechanical Circulatory Support Devices: An International Survey. Oral Presentation: ISHLT 35th Annual Meeting and Scientific Sessions, Nice, France Abstract published: Journal of Heart and Lung Transplantation, 2015
  • To L, Nemerovski CW, Kalus JS, Jennings DL.Readmission rates in patients with post- operative atrial fibrillation after cardiothoracic surgery and the impact of pharmacotherapy. Poster: ACCP Annual Meeting, Austin, TX. Abstract Published: Pharmacotherapy, 2014
  • Jennings DL, Wagner JL, Nemerovski CW, Kalus JS, Morgan JA, Lanfear DE. Epidemiology and Outcomes Associated With Anemia During Long-Term Continuous-Flow Left Ventricular Assist Device Support. Poster: ISHLT 34th Annual Meeting and Scientific Sessions, San Diego, CA Abstract published: Journal of Heart and Lung Transplantation, 2014
  • Jennings DL, Jacob M, Chopra A, Nemerovski CW, Morgan JA, Lanfear DE. Safety of Anticoagulation Reversal in Patients Supported With Continuous-Flow Left-Ventricular Assist Devices. Poster: ISHLT 34th Annual Meeting and Scientific Sessions, San Diego, Abstract published: Journal of Heart and Lung Transplantation, 2014
  • Jennings DL, Gellatly RM, Szandzik E, Leet A, Lanfear DE. Anticoagulation for the HeartWare HVAD: An International Comparison of Strategies and Outcomes. Poster: ISHLT, 34th Annual Meeting and Scientific Sessions, San Diego, CA Abstract published: Journal of Heart and Lung Transplantation, 2014
  • Jennings DL, Arter A, Morgan JA, Lanfear DE. Defining the Dose Response of Oral Sildenafil in Patients with Advanced Heart Failure. Poster: ACCP annual Meeting, Albuquerque, NM. Abstract Published: Pharmacotherapy, 2013
  • Kansagra J, Bryant M, Jennings D, Lanfear DE, Tita C, Brewer R, Morgan JA, Nemeh H, Williams C. Incidence and Associated Variable Cost of Hospital Readmission during Long- Term Continuous Flow Left Ventricular Assist Device (CF-LVAD) Implantation. Poster: Heart Failure Society of America Annual Scientific Meeting, Orlando, FL Abstract Published: Journal of Cardiac Failure, 2013
  • Jennings DL, Brewer R, Williams CT, Morgan JA. Impact of pre-operative ACE inhibitor exposure on the incidence of intraoperative and postoperative refractory vasoplegia in patients undergoing left-ventricular assist device implantation. Oral Presentation: ASAIO 59th Annual Meeting, Chicago, IL, Abstract Published: ASAIO Journal, 2013
  • Jennings DL, Chopra A, Chambers R, Williams CT, Morgan JA. Outcomes of chronic antimicrobial suppression therapy in patients with previous infection on continuous flow left ventricular device support. Poster: ASAIO 59th Annual Meeting, Chicago, IL, Abstract Published: ASAIO Journal, 2013
  • Jennings DL, Smith C, Williams CT. Use of pentoxiphylline for hemolytic anemia in a patient with a continuous-flow left-ventricular assist device. Poster: International Society of Heart and Lung Transplantation (ISHLT), 33rd Annual Meeting and Scientific Sessions, Montreal, Ca. Abstract published: Journal of Heart and Lung Transplantation, 2013
  • To L, Kalus JK, Nemerovski CW, Jennings DL. Rates of readmission in patients with post- operative atrial fibrillation after cardiothoracic surgery. Poster: ASHP Midyear Clinical Meeting, Las Vegas, NV. 12/2012
  • Jennings DL, Lekura J. Ability of a clinical pharmacist to make drug therapy interventions using email in patients with advanced heart failure and ventricular-assist devices. Poster: ACCP Annual Meeting, Hollywood, FL. Abstract published: Pharmacotherapy, 2012
  • Jennings DL, Sadik Z, Nemerovski CW, Kalus JS. Impact of platelet functional assays on the cost of treating suspected heparin induced thrombocytopenia (HIT). Poster: ACCP Annual Meeting, Hollywood, FL. Abstract published: Pharmacotherapy, 2012
  • Makowski CT, Chamber R, Jennings DL.Pharmacokinetics of vancomycin in patients with continuous flow left-ventricular assist devices. Poster: ACCP Annual Meeting, Hollywood, FL. Abstract published: Pharmacotherapy, 2012
  • Makowski CT, Jennings DL, Nemverovski CW, Kalus JS. Patient satisfaction with an inpatient pharmacist-directed anticoagulation service. Poster: ACCP Annual Meeting, Hollywood, FL. Abstract published: Pharmacotherapy, 2012
  • Williams CT, Jennings DL, Karadolian S, Chamaria S. Analysis of cost for readmissions after continuous flow left ventricular assist device implantation: A single center experience. Oral Presentation: American College of Cardiology Scientific Session, Chicago, IL. Abstract published: J Am Coll Cardiol 2012;59(13):E1018.
  • Jennings DL, Smith C, Brewer B, Williams CT. Opportunities for clinical pharmacist intervention in pharmacotherapy of patients with left-ventricular assist devices. Oral Presentation: ACCP Annual Meeting, Pittsburgh, PA. Abstract published: Pharmacotherapy, 2011
  • Jennings DL, Brewer B, Williams CT. Left-ventricular assist device implantation does not alter the pharmacodynamic response to warfarin. Poster: ACCP Annual Meeting, Pittsburgh, PA. Abstract published: Pharmacotherapy, 2011
  • Chamaria S, Jennings DL, Williams C. Initial clinical experience with oral sildenafil in patients with elevated pulmonary artery pressure after implantation of newer left- ventricular assist devices. Poster: American Society for Artificial Internal Organs Annual (ASAIO) Conference, Washington, DC. 06/2011
  • Jones M, Lanfear D, Jennings DL. Assessment of the heart failure pharmacotherapy of patients with continuous, axial‐flow left‐ventricular assist devices. Poster: ASHP Midyear Clinical Meeting, Anaheim, Ca. 12/2010
  • Smith Z, Jennings DL. Pharmacotherapy of patients with ST-segment elevation myocardial infarction undergoing rescue percutaneous coronary intevention. Poster: ASHP Midyear Clinical Meeting, Anaheim, Ca. 12/2010
  • Wong J, Lulek K, Jennings DL, Nemerovski CW, Kalus JS. Assessment of antiplatelet and anticoagulant use in the cardiac catheterization laboratory. Poster: ASHP Midyear Clinical Meeting, Anaheim, Ca. 12/2010
  • Jennings DL, McDonnell J, Schillig J. Evaluation of long-term anticoagulation in patients with left-ventricular assist devices. Poster: ACCP Annual Meeting in Austin, TX. Abstract Published: Pharmacotherapy, 2010
  • Jennings DL, Kheiri A, Kalus JS. An evaluation of employers’ perceptions on the value of a pharmacy resident teaching certificate program. Poster: ACCP Annual Meeting in Austin, TX. Abstract Published: Pharmacotherapy, 2010
  • Gross A, Jennings DL, Fleming J, Davis S. Healthcare Associated Infection in Patients with Left Ventricular Assist Devices. Poster: The 50th annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Boston, MA. 09/2010
  • Ma M, Jennings DL, Kalus JS. Hemodynamic and electrocardiographic effects of short-term cyanocobalamin administration on healthy volunteers. Poster: ASHP Midyear Meeting in Las Vegas, NV. 12/2009
  • Jennings DL, Kalus JS. Addition of cilostazol to aspirin and a thienopyridine for prevention of restenosis after coronary artery stenting: A meta-analysis. Oral Presentation: American Heart Association Scientific Sessions, New Orleans, LA. 11/2008 Abstract Published: Circulation, 2008
  • Jennings DL, Hansen L, Pallares MJ, Thompson A, Garrison K, Wessell AM. Assessment of Vitamin K Use in the Inpatient Treatment of Excessive Anticoagulation. Poster: American College of Clinical Pharmacy (ACCP) Annual Meeting, Denver, CO. 12/2007 Abstract Published: Pharmacotherapy, 2007
  • Jennings DL, Ragucci KR.Diabetes Quality of Life in an Ambulatory Care Clinic. Poster: University Health system Consortium, in conjunction with the American Society of Health-System Pharmacists Midyear Clinical Meeting in Anaheim, CA. 12/2006
  • Manierski C, Jennings DL, Kalus JS. Combination therapy with an ACE inhibitor and an angiotensin receptor blocker for diabetic nephropathy: A Meta-Analysis. Oral Presentation: American Society of Nephrology Renal Week in Philadelphia, PN. Abstract Published: J Am Soc Nephrol, 2005
  • Yagman LA, Petricca JC, Jennings DL, O’Dell K, Kalus JS. A Pilot Study to Evaluate Whether Patient Factors Predict Early Readmission After Acute Coronary Syndromes. Poster: American Society of Health-system Pharmacy (ASHP) Midyear Meeting, Orlando, FL Abstract Published: Am J Health-Syst Pharm, 2004

Honors/Awards

  • Faculty Scholarship Award, Arnold & Maria Schwartz College of Pharmacy, Long Island University, 2022
  • Finalist for the Nursing, Health Sciences and Allied Health Excellence in Research Award from the International Society of Heart and Lung Transplantation for the abstract titled, “Impact of Heart Failure Drug Therapy on Rates of Gastrointestinal Bleeding in LVAD Recipients: An INTERMACS Analysis.” 2020
  • American College of Clinical Pharmacy Cardiology PRN Clinical Practice Award, 2019
  • Finalist for the Nursing, Health Sciences and Allied Health Excellence in Research Award from the International Society of Heart and Lung Transplantation for the abstract titled, “Gut Microbial Diversity, Inflammation and Oxidative Stress is Associated with Tacrolimus Dosing Requirements Early after Heart Transplant.” 2019
  • Awarded Fellowship in the Heart Failure Society of America, 2019
  • Awarded Fellowship in the American College of Cardiology, 2016
  • Awarded Fellowship in the American Heart Association, 2015
  • Awarded Fellowship in the American College of Clinical Pharmacy, 2015
  • Travel Award, International Society of Heart and Lung Transplantation. Merit- based award for $1,000 funding to support presentation of oral abstract at annual meeting in Nice, France. 2015
  • Preceptor of the Year, Henry Ford Hospital Residency Program, 2012

Membership / Leadership

  • Member, Advanced Heart Failure and Transplant Leadership Council, American College of Cardiology
  • Member, Heart Failure Society of America
  • Member, American Heart Association, Clinical Cardiology Council
  • Member, International Society of Heart and Lung Transplantation
  • Member, American College of Cardiology
  • Member, American College of Clinical Pharmacy
  • Member, American Society of Health-System Pharmacists